Primary hepatic squamous cell carcinoma: case report and systematic review of the literature

被引：3

作者：

Zhao, Lin ^{[1
,2
,3
]}

Zhou, Yan ^{[1
,2
,3
]}

Ding, Jianmin ^{[1
,2
,3
]}

Qin, Zhengyi ^{[1
,2
,3
]}

Zhou, Hongyu ^{[1
,2
,3
]}

Jing, Xiang ^{[1
,2
,3
]}

机构：

[1] Third Cent Hosp Tianjin, Dept Ultrasound, Tianjin, Peoples R China

[2] Tianjin Third Cent Hosp, Tianjin Key Lab Extracorporeal Life Support Crit D, Tianjin, Peoples R China

[3] Tianjin Third Cent Hosp, Tianjin Inst Hepatobiliary Dis, Tianjin, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 13卷

关键词：

primary hepatic squamous cell carcinoma; clinical course; clinical characteristics; imaging findings; treatments and prognosis; EPIDERMOID CYST; LIVER; CANCER; HYPERCALCEMIA; ASSOCIATION; METASTASIS; TUMOR; RARE;

D O I：

10.3389/fonc.2023.1229936

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Primary hepatic squamous cell carcinoma (SCC) is extremely rare, and only a few dozen cases have been reported to date. It can barely be diagnosed before histopathological examination, which necessitates the exclusion of metastatic tumors. In this case, we present a 60-year-old female patient with no comorbidity. As laboratory tests and imaging examinations were not diagnostic, ultrasonography (US)-guided liver biopsy was performed and eventually revealed a definitive pathological diagnosis of hepatic SCC. After excluding metastasis, the diagnosis of primary hepatic SCC was established, and then chemotherapy and immunotherapy were performed. Additionally, a comprehensive literature search was conducted on primary hepatic SCC using PubMed, Google Scholar, and Web of Science, and a total of 53 articles were retrieved with a time range from 1972 to 2022. A critical analysis was then performed to evaluate previous literature focusing on the clinical characteristics, imaging features, treatments, and prognosis.

引用

页数：8

共 60 条

[1]

Abbas R, 2008, CAN J SURG, V51, pE85

[2]

ARASE Y, 1988, ACTA PATHOL JAPON, V38, P643

[3] PTHrP-producing tumor: Squamous cell carcinoma of the liver accompanied by humoral hypercalcemia of malignancy, increased IL-6 and leukocytosis [J].